Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 60,187 | 46,179 | 43,408 | 49,181 | 30,093 |
| Operating Income | -60,187 | -46,179 | -43,408 | -49,181 | -30,093 |
| Other Income | 3,733 | 4,073 | 4,611 | 4,424 | 1,658 |
| Pre-tax Income | -56,454 | -42,106 | -38,797 | -44,757 | -28,435 |
| Net Income Continuous | -56,454 | -42,106 | -38,797 | -44,757 | -28,435 |
| Net Income | $-56,454 | $-42,106 | $-38,797 | $-44,757 | $-28,435 |
| EPS Basic Total Ops | -705.20 | -526.11 | 617.42 | -1.03 | -566.46 |
| EPS Basic Continuous Ops | -0.71 | -0.53 | -2.65 | -1.03 | -0.57 |
| EPS Diluted Total Ops | -705.20 | -526.11 | 617.42 | -1.03 | -566.46 |
| EPS Diluted Continuous Ops | -0.71 | -0.53 | -2.65 | -1.03 | -0.57 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -0.53 | -0.49 | -1.03 | N/A |
| EBITDA(a) | $-59,996 | $-45,993 | $-43,214 | $-49,000 | $-29,912 |